Indian Transforming Alzheimer's Care Training (INTACT)
ConditionAlzheimer Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington State University
About this trial
INTACT will utilize a group-randomized trial, to test the effectiveness of a culturally informed provider training and "dementia friendly clinic" intervention for detection and appropriate management of AI/AN patients with ADRD and MCI in 28 urban and rural clinics serving AI/ANs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
A primary care clinic
Have at least 20 AI/AN active patients 55 years or older
Have an EHR system
Not intending to change EHR systems in the next year
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
INTACT Program
Other interventionThe INTACT Program has three components: 1. provide a training for Primary Care Providers (PCPs) training in screening, diagnosis, and care for ADRD, 2. at the PCP level, provide quarterly webinars. Topics will address driving and dementia; communication tips for someone with dementia; eating and drinking in advanced dementia; and advanced care planning for dementia. 3. At the clinic level, provide a workflow model for cognitive evaluation and setting a plan for the newly diagnosed patient. The INTACT intervention lasts 12 months and Continuing Medical Education credits will be available to PCPs who complete the INTACT training program
Treatment groups
28 Participants
are divided into 2 treatment groupsGroup A: InterventionExperimental treatment 1 intervention
Group B: WaitlistOther 1 intervention
Trial outcomes
Primary outcomes
1
Clinic Level - new diagnoses of ADRD and MCI (Aim 2)
Primary outcome (as obtained directly from EHRs) will reflect the aggregate counts of new diagnoses (MCI, ADRD, other dementia) during the study period, based on the ICD-10 codes for these diagnoses.
Time frame
Baseline and 12-month follow-up2
PCP level - care confidence (Aim 1)
Within each clinic, each participating PCP will complete a baseline and a 12-month follow-up survey. The PCP level primary outcome is care confidence in providing dementia care to patients and their families. Care confience wil be measured using the General Practitioners Confidence and Attitude scale for Dementia (GPACS-D) whic uses a 5 point Likert scale from 1 (strongly agree) to 5 (strongly disagree). The GPACS-D scale has 3 subscales: 1. Confidence in Clinical Abilities for which a lower score means a better outcome 2. Attitude to Care for which a lower score means a better outcome 3. Engagement for which a higher score means a better outcome
Time frame
Baseline and a 12-month follow-up3
Patient level - quality of care 1 (Aim 3)
Primary outcome (as obtained directly from EHRs) will reflect the number and type of ADRD diagnostic tests.
Time frame
Baseline and a 12-month follow-up4
Patient level - quality of care 2 (Aim 3)
Primary outcome (as obtained directly from EHRs) will reflect the number of prescriptions of appropriate medications for cognitive and mood symptoms.
Time frame
Baseline and a 12-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Washington State University
Lead sponsor
University of Washington
Collaborator
University of Miami
Collaborator
University of Minnesota
Collaborator
Source ClinicalTrials.gov